Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits
Journal of Ocular Pharmacology and Therapeutics · 01.11.2024 · 40 (9) · 588-595
DOI: 10.1089/jop.2024.0074 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, online erschienen am 15.11.2024. Verfasst von Christopher S Crean und 3 weiteren Autor:innen. Beteiligte Einrichtung: Xyzagen, Pittsboro, North Carolina, USA. Hauptthemen laut MEDLINE: Ophthalmic Solutions, Area Under Curve. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the ocular and systemic pharmacokinetics of lotilaner ophthalmic solution, 0.25%, following bilateral topical ocular administration of single and repeated doses in rabbits.
Methods
Dutch-belted rabbits ( n = 34) were administered lotilaner ophthalmic solution, 0.25%, eye drops, either in a single bilateral dose (Group 1) or twice a day bilaterally for 7 days and once on Day 8 (Group 2). The pharmacokinetics and tissue distribution levels of lotilaner were assessed following the single dose in Group 1 and the last dose in Group 2. The drug levels were examined in various ocular tissues and whole blood. The maximal concentration of the drug (Cmax), time to maximal concentration, the terminal phase elimination half-life, the area under the concentration–time curve (AUC), and total clearance of the drug were determined.
Results
In the eyelid margins, lotilaner exhibited the highest observed concentrations at 0.25 hour (h), presenting a mean Cmax of 14,600 ng/mL in Group 1 and 20,100 ng/mL in Group 2. The highest AUC was in the eyelid margin at 242,000 h×ng/mL in Group 1 and 535,000 h×ng/mL in Group 2. In the eyelid margin, the observed clearance rate (0.634 mL/h in single dose, 0.288 mL/h in repeat dose) was the slowest among all ocular tissues in both groups, with the longest half-life of 152 h (∼6.3 days) observed in the repeat dose group.
Conclusions
Lotilaner ophthalmic solution, 0.25%, demonstrated rapid ocular tissue absorption into the eyelid margin tissue with a long half-life of almost a week. No adverse effects were observed following topical ocular administration in Dutch-belted rabbits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Xyzagen, Pittsboro, North Carolina, USA.
- Virginia Eye Consultants, Norfolk, Virginia, USA.
- Periman Eye Institute, Seattle, Washington, USA.
- Tarsus Pharmaceuticals, Irvine, California, USA.
Zitieren
APA
Crean, C. S., Yeu, E., Maiti, S., & Neervannan, S. (2024). Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits. Journal of Ocular Pharmacology and Therapeutics, 40(9), 588-595. https://doi.org/10.1089/jop.2024.0074
Vancouver
Crean CS, Yeu E, Maiti S, Neervannan S. Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits. Journal of Ocular Pharmacology and Therapeutics. 2024;40(9):588-595. doi:10.1089/jop.2024.0074
BibTeX
@article{Crean2024,
author = {Crean, Christopher S and Yeu, Elizabeth and Maiti, Sathi and Neervannan, Sesha},
title = {Ocular and Systemic Pharmacokinetics of Lotilaner Ophthalmic Solution, 0.25%, Following a Single Dose or Repeated Doses in Dutch-Belted Rabbits},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
volume = {40},
number = {9},
pages = {588--595},
doi = {10.1089/jop.2024.0074}
}
EUVIMED